2016 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




Study Analyzes Factors in PAD Patients Who Chose Stenting Over Exercise

May 25, 2016 -- The Society for Vascular Surgery (SVS) announced findings from a study showing that veterans who could choose between regular exercise or endovascular therapy …

EVAS FORWARD-IDE Data Reported for Endologix's Nellix EVAS System

May 26, 2016 -- Endologix, Inc. announced positive clinical data from the investigational device exemption (IDE) clinical trial of the company’s Nellix endovascular…

SVS Calls for More Enrollment in BEST-CLI Trial

May 26, 2016 -- In a letter posted online earlier this week, Bruce A. Perler, President of the Society for Vascular Surgery (SVS), advised the society’s members that the…

Study Highlights Potential Cost Savings of Yttrium-90 Glass Microspheres to Treat HCC

May 26, 2016 -- BTG plc announced the presentation of new data highlighting that the transarterial radioembolization (TARE) treatment of hepatocellular carcinoma (HCC) us…

OrbusNeich Introduces Peripheral Artery Disease Device Portfolio

May 24, 2016 -- OrbusNeich announced that it has expanded its portfolio to include products to treat peripheral artery disease. The Jade and Scoreflex percutaneous translumina…

Surgical Specialties’ BioSentry Track Sealant System Approved for 17-Gauge Use in Europe

May 23, 2016 -- Surgical Specialties Corporation announced approval in Europe for expanded labeling for its BioSentry track sealant system, allowing the device to be used…

Society of NeuroInterventional Surgery Launches “Get Ahead of Stroke” Campaign

May 25, 2016 -- The Society of NeuroInterventional Surgery (SNIS) announced a new initiative, the “Get Ahead of Stroke” national public education and advocacy…

Click here for more News coverage

Current Supplement

Sponsored by Cook Medical

The Next Chapter in TEVAR

Moving Technology Toward Patient Needs

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




Vascular Market Price  Change
Abbott Laboratories $39.63  0.00%
AstraZeneca PLC $29.70  0.00%
Avinger $11.27  0.00%
Boston Scientific Corporation $22.71  0.00%
BTG plc $679.00  0.00%
Cardinal Health $78.95  0.00%
Cardiovascular Systems Inc. $16.89  0.00%
CR Bard Inc. $219.04  0.00%
Edwards Lifesciences Corp. $98.50  0.00%
Endologix Inc. $12.67  0.00%
Vascular Market Price  Change
Johnson and Johnson $112.69  0.00%
Lombard Medical, Inc. $1.41  0.00%
Medtronic, Inc. $80.48  0.00%
Merit Medical Systems, Inc. $18.77  0.00%
Penumbra, Inc. $52.79  0.00%
St. Jude Medical Inc. $78.36  0.00%
Stryker $111.16  0.00%
The Medicines Company $37.61  0.00%
The Spectranetics Corporation $18.32  0.00%
Vascular Solutions Inc. $38.09  0.00%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.